Continuous subcutaneous levodopa-carbidopa infusion for Parkinson's disease. Moes HR, Buskens E, van Laar T. Lancet Neurol 2024;23:856-857.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Moes HR, Buskens E, van Laar T. Continuous subcutaneous levodopa-carbidopa infusion for Parkinson's disease. Lancet Neurol 2024;23:856-857.
PMID: 39152017